MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/1940-0640-9-16

Медицинская библиотека · Addiction science & clinical practice · 2014

Costs of care for persons with opioid dependence in commercial integrated health systems.

Lynch Frances L, McCarty Dennis, Mertens Jennifer, Perrin Nancy A, Green Carla A, Parthasarathy Sujaya, Dickerson John F, Anderson Bradley M, Pating David

Сравнительное исследованиеСтатьяПоддержка NIH: внешняя программаПеревод пока не подготовлен

Аннотация

BACKGROUND

When used in general medical practices, buprenorphine is an effective treatment for opioid dependence, yet little is known about how use of buprenorphine affects the utilization and cost of health care in commercial health systems.

METHODS

The objective of this retrospective cohort study was to examine how buprenorphine affects patterns of medical care, addiction medicine services, and costs from the health system perspective. Individuals with two or more opioid-dependence diagnoses per year, in two large health systems (System A: n = 1836; System B: n = 4204) over the time span 2007-2008 were included. Propensity scores were used to help adjust for group differences.

RESULTS

Patients receiving buprenorphine plus addiction counseling had significantly lower total health care costs than patients with little or no addiction treatment (mean health care costs with buprenorphine treatment = $13,578; vs. mean health care costs with no addiction treatment = $31,055; p < .0001), while those receiving buprenorphine plus addiction counseling and those with addiction counseling only did not differ significantly in total health care costs (mean costs with counseling only: $17,017; p = .5897). In comparison to patients receiving buprenorphine plus counseling, those with little or no addiction treatment had significantly greater use of primary care (p < .001), other medical visits (p = .001), and emergency services (p = .020). Patients with counseling only (compared to patients with buprenorphine plus counseling) used less inpatient detoxification (p < .001), and had significantly more PC visits (p = .001), other medical visits (p = .005), and mental health visits (p = .002).

CONCLUSIONS

Buprenorphine is a viable alternative to other treatment approaches for opioid dependence in commercial integrated health systems, with total costs of health care similar to abstinence-based counseling. Patients with buprenorphine plus counseling had reduced use of general medical services compared to the alternatives.

Для цитирования: Lynch Frances L, McCarty Dennis, Mertens Jennifer, Perrin Nancy A, Green Carla A, Parthasarathy Sujaya, Dickerson John F, Anderson Bradley M, Pating David. Costs of care for persons with opioid dependence in commercial integrated health systems.. Addiction science & clinical practice. 2014. DOI: 10.1186/1940-0640-9-16.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.